Saturday, September 17, 2011

Article on implications of PLIVA v. Mensing

In PLIVA v. Mensing, 131 S. Ct. 2567 (2011), the Supreme Court held that FDA regulations governing the labeling of prescription drugs preempt state-law failure-to-warn claims against generic drug manufacturers. Here is a link to a recent article on Mensing and its implications.

Thanks to Public Citizen for the link.

No comments: